The landscape of dementia prognosis has progressed dramatically with the arrival of innovative biomarkers, such as amyloid PET scans, tau imaging, and blood-based tests which can detect Alzheimer's pathology several years before signs arise. Even though these technological advancements depict impressive progress in comprehending neurodegenerative ailments, they have not diminished https://geoffreyv874vfp4.theisblog.com/profile